| Application no. and date | 10727611.5 (espacenet) (Federated) (European Patent Register), 20100615 | | Patent/reg. no. and date | DK/EP 2442791, 20191127 | | Publication date | 20120425 | | Priority no. and date | US 187442 P, 20090616 | | EP pub. no. and date |
EP 2442791 20120425 | | Effective date | | | Applicant/owner | Pfizer Inc., 235 East 42nd Street
New York, NY 10017, US,
Bristol-Myers Squibb Holdings Ireland
Unlimited Company, Hinterbergstrasse 16
6312 Steinhausen, CH | | Applicant ref. no. | V152945 | | Inventor | NAUSE, Richard, G., C/o Pfizer Inc.
Easton Point Rd.
Ms 8156-21
Groton, CT 06340, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/4545 (2006.01) , A61K 9/16 (2006.01) , A61K 9/20 (2006.01) , A61P 7/02 (2006.01) | | Title | FORMER TIL DOSERING AF APIXABAN | | Int. application no. | US2010038660 | | Int. publication no. | WO2010147978 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
